Aravive Inc.

5.49-0.3600-6.15%Vol 258.12K1Y Perf -25.23%
Apr 9th, 2021 16:00 DELAYED
BID5.43 ASK5.56
Open5.84 Previous Close5.85
Pre-Market- After-Market-
 - -  - -%
Target Price
22.50 
Analyst Rating
Strong Buy 1.00
Potential %
309.84 
Finscreener Ranking
★★★★★ —    59.47
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★+     54.14
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★+ —    50.44
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap107.93M 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
11.43 
Earnings Date
5th May 2021

Today's Price Range

5.445.86

52W Range

4.2714.94

5 Year PE Ratio Range

-2.20-1.10

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-14.49%
1 Month
-21.01%
3 Months
-2.31%
6 Months
5.58%
1 Year
-25.23%
3 Years
-42.81%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ARAV5.49-0.3600-6.15
AAPL132.992.63002.02
GOOG2 285.8820.44000.90
MSFT255.852.60001.03
XOM55.87-0.1300-0.23
WFC40.500.47001.17
JNJ161.25-1.7200-1.06
FB312.46-0.5600-0.18
GE13.600.15001.12
JPM156.281.16000.75
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.52-0.2551.92
Q03 2020-0.42-0.66-57.14
Q02 2020-0.45-0.3228.89
Q01 2020-0.34-0.53-55.88
Q04 2019-0.53-0.3533.96
Q03 2019-0.50-0.54-8.00
Q02 2019-0.56-0.2751.79
Q01 2019-0.79-0.4246.84
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.4511.76Positive
6/2021 QR-0.4811.11Positive
12/2021 FY-1.898.25Positive
12/2022 FY-2.122.75Positive
Next Report Date5th May 2021
Estimated EPS Next Report-0.45
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume258.12K
Shares Outstanding19.66M
Trades Count2.26K
Dollar Volume823.72K
Avg. Volume221.05K
Avg. Weekly Volume182.84K
Avg. Monthly Volume329.05K
Avg. Quarterly Volume230.45K

Aravive Inc. (NASDAQ: ARAV) stock closed at 5.49 per share at the end of the most recent trading day (a -6.15% change compared to the prior day closing price) with a volume of 259.17K shares and market capitalization of 107.93M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 17 people. Aravive Inc. CEO is Gail McIntyre.

The one-year performance of Aravive Inc. stock is -25.23%, while year-to-date (YTD) performance is -2.66%. ARAV stock has a five-year performance of %. Its 52-week range is between 4.27 and 14.94, which gives ARAV stock a 52-week price range ratio of 11.43%

Aravive Inc. currently has a PE ratio of -3.30, a price-to-book (PB) ratio of 2.70, a price-to-sale (PS) ratio of 20.96, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -38.88%, a ROC of -53.86% and a ROE of -49.57%. The company’s profit margin is -%, its EBITDA margin is -636.00%, and its revenue ttm is $5.69 Million , which makes it $0.29 revenue per share.

Of the last four earnings reports from Aravive Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.45 for the next earnings report. Aravive Inc.’s next earnings report date is 05th May 2021.

The consensus rating of Wall Street analysts for Aravive Inc. is Strong Buy (1), with a target price of $22.5, which is +309.84% compared to the current price. The earnings rating for Aravive Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Aravive Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Aravive Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 13.05, ATR14 : 0.64, CCI20 : 1.39, Chaikin Money Flow : -0.01, MACD : 0.15, Money Flow Index : 36.99, ROC : -8.28, RSI : 56.46, STOCH (14,3) : 47.60, STOCH RSI : 1.00, UO : 43.81, Williams %R : -52.40), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Aravive Inc. in the last 12-months were: Amato Giaccia (Option Excercise at a value of $725)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (100.00 %)
4 (100.00 %)
4 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Aravive Inc.

Aravive Inc is a clinical-stage biotechnology company. It focuses on developing therapies that target important survival pathways for both solid tumors as well as hematologic malignancies. The company's lead candidate AVB-500 is developed as a targeted therapy against ovarian cancer.

CEO: Gail McIntyre

Telephone: +1 936 355-1910

Address: 3730 Kirby Drive, Houston 77010, TX, US

Number of employees: 17

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

58%42%

Bearish Bullish

48%52%

Bearish Bullish

66%34%

News

Stocktwits